Green Thumb Industries (GTBIF) EPS (Basic) Growth (3y) (2022 - 2026)
Green Thumb Industries (GTBIF) EPS (Basic) Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | -35.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.40% |
| Mar 31, 2026 | 18.10% |
| Dec 31, 2025 | 61.49% |
| Sep 30, 2025 | 33.88% |
| Jun 30, 2025 | -69.03% |
| Mar 31, 2025 | -34.37% |
| Dec 31, 2024 | -9.12% |
| Sep 30, 2024 | -26.94% |
| Jun 30, 2024 | -5.87% |
| Mar 31, 2024 | 35.70% |
| Dec 31, 2023 | 49.22% |
| Sep 30, 2023 | -3.82% |
| Jun 30, 2023 | 44.65% |
| Mar 31, 2023 | 61.27% |
| Dec 31, 2022 | -75.17% |
| Sep 30, 2022 | 37.71% |
| Jun 30, 2022 | 42.94% |
| Mar 31, 2022 | 60.94% |